Analytical and biological characterization of supercoiled plasmids purified by various chromatographic techniques

DNA and Cell Biology

Volumn 24, Issue 12, 2005, Pages 819-831

  Tumanova, Irina ^a   Boyer, Jean ^b   Ausar, S Fernando ^c   Burzynski, Joseph ^a   Rosencrance, Dana ^a   White, Julie ^a   Scheidel, Jason ^a   Parkinson, Rose ^b   Maguire, Henry ^b   Middaugh, C Russell ^c   Weiner, David ^b   Green, Anthony P ^a  

^a Puresyn Inc   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMATOGRAPHY; CIRCULAR DICHROISM; COW; DIFFERENTIAL SCANNING CALORIMETRY; GENE DELIVERY SYSTEM; GENE THERAPY; IMMUNIZATION; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; PLASMID; PRIORITY JOURNAL; PURIFICATION; QUALITY CONTROL; SEPARATION TECHNIQUE; SERUM; STORAGE TEMPERATURE; TECHNIQUE; THERMAL EXPOSURE; THERMOSTABILITY;

BIOPHYSICS; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY; CIRCULAR DICHROISM; DNA, SUPERHELICAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; PLASMIDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

BOVINAE;

EID: 29244454267     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.819     Document Type: Article

References (38)

1. AKAHATA W., YANG, Z.Y., and NABEL, G.J. (2005). Comparative immunogenicity of human immunogenicity virus particles and corresponding polypeptides in a DNA vaccine. J. Virol. 79, 626-631.
2. BRAUN, C.S., JAS, G.S., CHOOSAKOONKRIANG, S., KOE, G.S., SMITH, J.G., and MIDDAUGH, C.R. (2003). The structure of DNA within cationic lipid/DNA complexes. Biophys. J. 84, 1114-1123.
3. CHOOSAKOONKRIANG, S., KOE, G.S., SMITH, J.G., and MIDDAUGH, C.R. (2003a). Biophysical characterization of PEI/DNA complexes. J. Pharm. Sci. 92, 1710-1722.
4. CHOOSAKONKRIANG, S., WIETHOFF C.M., KOE, G.S., KOE, J.G., ANCHORDOQUY, T.J., and MIDDAUGH, C.R. (2003b). An infrared spectroscopic study of the effect of hydraqtion on cationic lipid/DNA complexes. J. Pharm. Sci. 92, 115-130.
5. DERRICK, S.C., YANG, A.L., and MORRIS, S.L. (2004). A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23, 780-788.
6. DIOGO, M.M., QUEIROZ, J.A., MONTEIRO, G.A., MARTINS, S.A., FERREIRA, G.N., and PRAZERES, D.M. (2000). Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol Bioeng. 68, 576-583.
7. DIOGO, M.M., QUEIROZ, J.A., and PRAZERES, D.M. (2001a). Studies on the retention of plasmid DNA and Escherichia coli nucleic acids by hydrophobic interaction chromatography. Bioseparation 10, 211-220.
8. DIOGO, M.M., RIBEIRO, S.C., QUEIROZ, J.A., MONTEIRO, G.A., TORDO, N., PERRIN, P., and PRAZERES, D.M. (2001b). Production, purification and analysis of an experimental DNA vaccine against rabies. J. Gene Med. 3, 577-584.
9. EON-DUVAL, A., and BURKE, G. (2004). Purification of pharmaceutical-grade DNA by anion-exchange chromatography in an RNase-free process. J. Chromatogr. B 804, 327-335.
10. EVANS, R.K., XU, Z., BOHANNON, K.E., WANG, B., BRUNER, M.W., and VOLKIN, D.B. (2000). Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J. Pharm. Sci. 89, 76-87.
11. GEBREKIDAN, S., WOO, B.H., and DELUCA, P.P. (2000). Formulation and in vitro transfection efficiency of poly (D, L-lactide-coglycolide) microspheres containing plasmid DNA for gene delivery. AAAPS PharmSci. Tech. 1, E28-E34.
12. GREEN, A. (1999). Purification of supercoiled plasmids. In DNA Vaccines: Methods and Protocols. D. Lowrie and R. Whalen, eds. (Humana Press, Totowa, NJ.) p. 1-9.
13. GREEN, A., HUANG, J., SCOTT, M., KIERSTEAD, T., BEAUPRÉ, I., GAO, G.-P., and WILSON, J. (2002). A new scaleable method for the purification of recombinant adenovirus vectors. Hum. Gene Ther. 13, 1921-1934.
14. GREEN, A.P., PRIOR, G.M., HELVESTON, N., TAITTINGER B., LIU, X., and THOMPSON, J.A. (1997). Preparative purification of supercoiled plasmid DNA for therapeutic applications. BioPharmacology 10, 52-62.
15. HORN, N.A., MEEK, J.A., BUDAHAZI, G., and MARQUET, M. (1995). Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials. Hum. Gene Ther. 6, 565-573.
16. KNIGHT, J.D., and ADAMI, R.C. (2003). Stabilization of DNA utilizing divalent cations and alcohol. Int. J. Pharm. 264, 15-24.
17. KUTZLER, M., and WEINER, D. (2004). Developing DNA vaccines that call to dendritic cells. J. Clin. Invest 114, 1241-1244.
18. LIM, H.M., LEWIS, D.E., LEE, H.J., LIU, M., and ADHYA, S. (2003). Effect of varying the supercoiling of DNA on transcription and its regulation. Biochemistry 42, 10718-10725.
19. LOBO, B.A., ROGERS, S.A., CHOOSAKOONKRIANG, S., BOGDANOWICH-KNIPP, S., SMITH, J.G., KOE, G., and MIDDAUGH, C.R. (2002). Alteration of the thermal stability of plasmid DNA by cationic lipids and polymers. J. Pharm. Sci. 91, 454-466.
20. LOBO, B.A., VETRO, J.A. SUICH, D.M., ZUCKERMAN, R.N., and MIDDAUGH, C.R. (2003). Structure/function analysis of peptoid/lipotoid: DNA complexes. J. Pharm. Sci. 92, 1905-1918.
21. MANCINI-BOURGINE, M., FONTAINE, H., SCOTT-ALGARA, D., POL, S., BRECHOT, C., and MICHEL, M.L. (2004). Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology 40, 874-882.
22. MARSHALL, J., NIETUPSKI, J.B., LEE, E.R., SIEGEL, C.S., RAFTER, P.W., RUDGINSKY, S.A., CHANG, C.D., EASTMAN, S.J. HARRIS, D.J., SCHEULE, R.K., et al. (2000). Cationic lipid structure and formulation considerations for optimal gene transfection of the lung. J. Drug Target. 7, 453-469.
23. MARTIN, J.E., ENAMA, M.E., KOUP, R.A., BAILER, R.T., MOODIE, Z., ROEDERER, M., NABEL, G.J., and GRAHAM, G.S. (2005). VRC004: Safety and immunogenicity of a multiclade HIV-1 DNA vaccine in healthy uninfected adults (VRC-HIVDNA009-00-VP). J. Allergy Clin. Immunol. 115, 892.
24. MASCOLA, J.R., SAMBOR, A., BEAUDRY, K., SANTRA, S., WELCHER, B., LOUDER, M.K., VANCOTT, T.C., HYANG, Y., CHAKRABARTI, G.K., KONG, W.P., et al. (2005). Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J. Virol. 79, 771-779.
25. MIDDAUGH, C.R., EVANS, R.K., MONTGOMERY, D.L., and CASIMIRO, D.R. (1998). Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87, 130-146.
26. MOUNT, C.N., LEE, L.K., YASIN, A., SCOTT, A., FEARN, T., and SHAMLOU, P.A. (2003). The influence of physico-chemical and process conditions on the physical stability of plasmid DNA complexes using response surface methodology. Biotech. Appl. Biochem. 37, 225-234.
27. PROKOP, A., KOZLOV, E., MOORE, W., and DAVIDSON, J.M. (2002). Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. J. Pharm. Sci. 91, 67-76.
28. REXROAD, J., WIETHOFF, C.M., GREEN, A.P., KIERSTEAD, T.D., SCOTT, M.O., and MIDDAUGH, C.R. (2003). Structural stability of adenovirus type 5. J. Pharm Sci. 92, 665-678.
29. RIEMENSCHNEIDER, J., GARRISON, A., GEISBERT, J., JAHRLING, P., HEVEY, M., NEGLEY, D., SCHMALJOHN, A., LEE, J., HART, M.K., VANDERZANDEN, L., et al. (2003). Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 21, 4071-4080.
30. SINGH, D.K., LIU, Z., SHEFFER, D., MACKAY, G.A., SMITH, M., DHILLON, S., HEGDE, R., JIA, F., ADANY, I., and NARAYAN, O. (2005). A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. J. Virol. 79, 3419-3428.
31. SMITH, J.M., AMARA, R.R., WYATT, L.S., ELLENBERGER, D.L., LI, B., HERNDON, J.G., PATEL, M., SHARMA, S., CHENNAREDDI, L., BUTERA, S., et al. (2005). Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses. AIDS Res. Hum. Retroviruses 21, 140-144.
32. SMOOKER, P.M., RAINCZUK, A., KENNEDY, N., and SPITHILL, T.W. (2004). DNA vaccines and their application against parasites-Promise, limitations and potential solutions. Biotechnol. Ann. Rev. 10, 189-236.
33. STADLER, J., LEMMENS, R., and NYHAMMER, T. (2004). Plasmid DNA purification. J. Gene Med. 6, S54-S66.
34. SUMIDA, S., MCKAY, P., TRUITT, D., KISHKO, M., ARTHUR, J., SEAMAN, M., JACKSON, S., GORGONE, D., LIFTON, M., LETVIN, N., et al. (2004). Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J. Clin. Invest. 114, 1334-1342.
35. URTHALER, J., SCHLEGL, R., PODGORNIK, A., STRANCAR, AL, JUNGBAUER, A. and NECINA, R. (2004). Application of monoliths for plasmid DNA purification: Development and transfer to production. J. Chromatogr 1065, 93-106.
36. WANG, D., CHRISTOPHER, M.E., NAGATA, L.P., ZABIELSKI, M.A., LI, H., WONG, J.P., and SAMUEL, J. (2004). Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. J. Clin. Virol. 31(Suppl 1), S99-S106.
37. WANG, R., RICHIE, T.L., BARACEROS, M.F., RAHARDJO, N., GAY, T., BANANIA, J.G., CHAROENVIT, Y., EPSTEIN, J.E., LUKE, T., FREILICH, D.A., et al. (2005). Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect. Immun. 73, 2863-2872.
38. WIETHOFF, C.M., KOE, J.G., KOE, G.S., and MIDDAUGH, C.R. (2004). Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture. J. Pharm. Sci. 93, 108-123.